Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated December 21, 2020, titled "Glenmark Pharmaceuticals receives ANDA tentative approval for Dabigatran Etexilate Capsules, 75 mg, 110 mg, and 150 mg".
Press Release Dec 21 2020
Filed with NSE ·
6ix hasn’t read this filing yet.
Glenmark Pharmaceuticals Limited on 6ix
Earlier from Glenmark Pharmaceuticals
- Press Release Dec 01 2020
- Press Release Nov 28 2020
- Press Release Nov 26 2020
- Press Release Nov 23 2020
- Press Release Nov 11 2020
Later from Glenmark Pharmaceuticals
- Press Release Dec 23 2020
- Press Release Dec 29 2020
- Press Release Dec 31 2020
- Press Release Jan 28 2021
- Press Release Feb 03 2021
Follow Glenmark Pharmaceuticals into a list and get an email when it puts out news.
Follow Glenmark Pharmaceuticals